Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)

Clinical trial NCT01394952 · COMPLETED

Trial details

NCT number: NCT01394952
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease Diabetes Mellitus, Type 2

Start date: 2011-07-22
Primary completion: 2018-08-21
Enrollment: 9901

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.